Loading…
Unichem Laboratories (UNICHEMLAB)₹509.15+1.30%Pharmaceuticals
Unichem Laboratories is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 11.7 against a peer median of 44.5, and ROCE of 4.0% against a peer median of 8.5%, and latest-quarter sales growth of 20.0% against a peer median of 22.3%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aarti Drugs | 4,563 | 24.0 | 12.1 | 13.4 | 0.37 | 0.4 | 2,564 | 194 | 18.9 | −7.5 | vs UNICHEMLAB |
| Zota Health Care | 4,410 | — | −8.0 | −15.1 | 0.39 | 0.1 | 539 | −74 | 54.2 | — | vs UNICHEMLAB |
| Evonile Pharma | 4,343 | 44.5 | 16.0 | 11.7 | 0.00 | 0.0 | 353 | 93 | 18.1 | 14.3 | vs UNICHEMLAB |
| RPG Life Sciences | 4,283 | 39.1 | 26.0 | 19.3 | 0.03 | 0.9 | 708 | 115 | 16.4 | −24.3 | vs UNICHEMLAB |
| Gujarat Themis Biosyn | 4,138 | 88.5 | — | — | — | 0.2 | 165 | 47 | 22.3 | 22.5 | vs UNICHEMLAB |
| Kwality Pharmaceuticals | 4,011 | 49.3 | 24.0 | 22.9 | 0.39 | 0.0 | 503 | 67 | 46.0 | 116.4 | vs UNICHEMLAB |
| Shukra Pharmaceuticals | 3,618 | 110.9 | 36.9 | 28.9 | 0.06 | 0.0 | 57 | 22 | 379.2 | 1,191.1 | vs UNICHEMLAB |
| Unichem Laboratories | 3,584 | 11.7 | 4.0 | 3.2 | 0.18 | 0.0 | 2,200 | 253 | 20.0 | — | — |
| Solara Active Pharma Sciences | 3,143 | 91.9 | 5.0 | −0.1 | 0.41 | 0.0 | 1,374 | −7 | 32.8 | — | vs UNICHEMLAB |
| Ind-Swift Laboratories | 3,037 | 36.1 | 5.0 | 4.0 | 0.01 | 0.0 | 649 | 43 | 51.1 | 325.2 | vs UNICHEMLAB |
| Hikal | 2,772 | — | 4.0 | 2.9 | 0.57 | 0.3 | 1,714 | −49 | 6.0 | — | vs UNICHEMLAB |
| Peer median | 4,011 | 44.5 | 8.5 | 7.8 | 0.28 | 0.0 | 649 | 47 | 22.3 | 22.5 |
Listed companies closest to Unichem Laboratories in Pharmaceuticals include Aarti Drugs, Zota Health Care, Evonile Pharma, RPG Life Sciences, Gujarat Themis Biosyn, Kwality Pharmaceuticals, Shukra Pharmaceuticals, Solara Active Pharma Sciences.
Aarti Drugs, with a market cap of ₹4,563 Cr.
Unichem Laboratories trades at a P/E of 11.7; the median of its peer set is 44.5. A P/E above or below the median is a description, not a judgement on value.
Unichem Laboratories' return on capital employed is 4.0%, below the peer median of 8.5%.